Physician profile
Bruce Breit
NPI 1639261738
$1,085.25
in general payments reported to CMS, 2019-2025
20 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $47.71 · 2022: $236 · 2023: $205 · 2024: $268 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $692.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $260.47 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $122.84 | 2020-2025 | Injectafer |
| Abbvie INC. | $99.06 | 2019-2024 | Lo Loestrin Fe |
| Organon LLC | $95.09 | 2022-2024 | Nexplanon |
| Coopersurgical, INC. | $73.41 | 2019-2025 | Paragard T 380a, Sos |
| Evofem Biosciences, INC. | $70.48 | 2022-2023 | Phexxi |
| Hologic Sales and Service, LLC | $54.45 | 2020-2025 | Novasure |
| Biogen, INC. | $47.34 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $37.34 | 2019 | |
| Sumitomo Pharma America, INC. | $35.34 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $33.06 | 2022 | |
| Therapeuticsmd, INC. | $29.14 | 2019-2022 | |
| Sage Therapeutics, LLC | $28.05 | 2022 | |
| Shield Therapeutics INC | $18.91 | 2025 | |
| Mayne Pharma Commercial LLC | $16.52 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $15.65 | 2019 | |
| Guard Medical INC. | $14.54 | 2024 | Npseal Large |
| Millicent US INC | $12.43 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.97 | 2019 | |
| Meditrina | $9.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Breit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.